Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor SAN DIEGO, Aug. 1, 2025 /PRNewswire/ -- Blacksmith Medicines, Inc. (Blacksmith), a leading biopharma dedicated to discovering and...
Hence then, the article about blacksmith medicines co founder presents at the 21st international conference on biological inorganic chemistry was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Blacksmith Medicines Co-Founder Presents at the 21st International Conference on Biological Inorganic Chemistry )
Also on site :
- Anthropic accuses Chinese AI labs of mining Claude as US debates AI chip exports
- The best Crazy Time apps to download and play in Bangladesh
- Canaan Inc. Acquires Cipher Mining's Interest in Multiple Operational Mining Projects Totaling ~4.4 EH/s in West Texas
